Evidence map›Paper›PMID 36149812›Full record

ArticleEmerging microbes & infections2022

Influence of Zika virus 3'-end sequence and nonstructural protein evolution on the viral replication competence and virulence.

Hae-Gwang Jung, Hee Cho, Minwoo Kim, Haewon Jung, Yeonju Bak, Se-Young Lee, Han Young Seo, Yu-Min Son, Hawon Woo, Gone Yoon and 2 more

Open access · goldAbstract read
In one paragraph

Article in Emerging microbes & infections, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Genetically modified ZIKA virus as a microRNA-sensitive oncolytic virus against central nervous system tumors.Molecular therapy : the journal of the American Society of Gene Therapy · 2024
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Hae-Gwang JungDepartment of Biotechnology, Yonsei University, Seoul, South Korea.
Hee ChoDepartment of Biotechnology, Yonsei University, Seoul, South Korea.
Minwoo KimDepartment of Biotechnology, Yonsei University, Seoul, South Korea.
Haewon JungDepartment of Biotechnology, Yonsei University, Seoul, South Korea.
Yeonju BakDepartment of Biotechnology, Yonsei University, Seoul, South Korea.
Se-Young LeeDepartment of Biotechnology, Yonsei University, Seoul, South Korea.
Han Young SeoDepartment of Biotechnology, Yonsei University, Seoul, South Korea.
Yu-Min SonDepartment of Biotechnology, Yonsei University, Seoul, South Korea.
Hawon WooDepartment of Biotechnology, Yonsei University, Seoul, South Korea.
Gone YoonDepartment of Biotechnology, Yonsei University, Seoul, South Korea.
Seong-Jun KimCenter for Convergent Research of Emerging Virus Infection, Korea Research Institute of Chemical Technology, Daejeon, South Korea.ORCID 0000-0001-8504-2872
Jong-Won OhDepartment of Biotechnology, Yonsei University, Seoul, South Korea.ORCID 0000-0001-8851-234X
Yonsei University · KRKorea Research Institute of Chemical Technology · KR

Funding

NIEHS NIH HHS 27307C0010
6 · The paper itself

Abstract

Zika virus (ZIKV) has been circulating in human networks over 70 years since its first appearance in Africa, yet little is known about whether the viral 3'-terminal sequence and nonstructural (NS) protein diverged genetically from ancient ZIKV have different effects on viral replication and virulence in currently prevailing Asian lineage ZIKV. Here we show, by a reverse genetics approach using an infectious cDNA clone for a consensus sequence (Con1) of ZIKV, which represents Asian ZIKV strains, and another clone derived from the MR766 strain isolated in Uganda, Africa in 1947, that the 3'-end sequence -UUUCU-3' homogeneously present in MR766 genome and the -GUCU-3' sequence strictly conserved in Asian ZIKV isolates are functionally equivalent in viral replication and gene expression. By gene swapping experiments using the two infectious cDNA clones, we show that the NS1-5 proteins of MR766 enhance replication competence of ZIKV Con1. The Con1, which was less virulent than MR766, acquired severe bilateral hindlimb paralysis when its NS1-5 genes were replaced by the counterparts of MR766 in type I interferon receptor (IFNAR1)-deficient A129 mice. Moreover, MR766 NS5 RNA-dependent RNA polymerase (RdRp) alone also rendered the Con1 virulent, despite there being no difference in RdRp activity between MR766 and Con1 NS5 proteins. By contrast, the Con1 derivatives expressing MR766 Nsps, like Con1, did not develop severe disease in wild-type mice treated with an IFNAR1 blocking antibody. Together, our findings uncover an unprecedented role for ZIKV NS proteins in determining viral pathogenicity in immunocompromised hosts.

Indexed as

Zika VirusZika Virus InfectionAnimalsDNA, ComplementaryHumansMiceReceptor, Interferon alpha-betaRNA-Dependent RNA PolymeraseUgandaViral Nonstructural ProteinsVirulenceVirus ReplicationDNA, ComplementaryReceptor, Interferon alpha-betaRNA-Dependent RNA PolymeraseViral Nonstructural Proteins3′-end sequence variantsinfectious cDNA clonenonstructural proteinsvirulence determinantZika virus

Identifiers

PMID36149812
PMCPMC9621255
OpenAlexW4296799462

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.